CI Investments Inc’s Kezar Life Sciences KZR Stock Holding History

CI Investments Inc’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,173	Closed	-$527K	–	1337
2022 Q1	$527K	Buy	+3,173	New	+$455K	﹤0.01%	527

Other funds holding KZR

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CI Investments Inc's KZR Position: Q2 2022 in Review

CI Investments Inc sold out of Kezar Life Sciences (KZR) in Q2 2022, closing a stake of 3,173 shares — an estimated $527K sold.

CI Investments Inc first reported a position in KZR in Q1 2022 and held it in 1 quarter. The position peaked at $527K in Q1 2022. 127 funds tracked by Wall St. Rank hold KZR as of Q2 2022.

CI Investments Inc reported no remaining Kezar Life Sciences position as of Q2 2022 after selling out during the quarter.
CI Investments Inc sold 3,173 Kezar Life Sciences shares in Q2 2022, an estimated $527K.
CI Investments Inc first reported a position in Kezar Life Sciences in Q1 2022 and held it in 1 quarter.
CI Investments Inc's Kezar Life Sciences position peaked at $527K in Q1 2022.
127 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2022.

Based on CI Investments Inc's 13F filing for Q2 2022, filed 12 Aug 2022.